UNDERWRITING AGREEMENTUnderwriting Agreement • November 21st, 2023 • Impact Biomedical Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 21st, 2023 Company Industry Jurisdiction
SHARE EXCHANGE AGREEMENT by and among IMPACT BIOMEDICAL INC. and dss biohealth security, inc. Dated as of October 31, 2023 SHARE EXCHANGE AGREEMENT Dated as of October 31, 2023Share Exchange Agreement • November 21st, 2023 • Impact Biomedical Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 21st, 2023 Company Industry JurisdictionThis Share Exchange Agreement (this “Agreement”) is entered into as of the date first set forth above (the “Closing Date”) by and between Impact BioMedical Inc. (the “Company”) and DSS BioHealth Security, Inc., a Nevada corporation (“DBH”). The Company and DBH may be referred to herein individually as a “Party” and collectively as the “Parties.”
ContractPurchase Warrant Agreement • November 21st, 2023 • Impact Biomedical Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 21st, 2023 Company Industry JurisdictionTHE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING [●], 2023 (THE “EFFECTIVE DATE”) TO ANYONE OTHER THAN (I) AEGIS CAPITAL CORP. OR AN UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING FOR WHICH THIS PURCHASE WARRANT WAS ISSUED TO THE UNDERWRITER AS CONSIDERATION (THE “OFFERING”), OR (II) A BONA FIDE OFFICER OR PARTNER OF AEGIS CAPITAL CORP. OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER.